Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 022023

Expand all

EMEND (FOSAPREPITANT DIMEGLUMINE)
EQ 150MG BASE/VIAL
Marketing Status: Prescription

Active Ingredient: FOSAPREPITANT DIMEGLUMINE
Proprietary Name: EMEND
Dosage Form; Route of Administration: POWDER; INTRAVENOUS
Strength: EQ 150MG BASE/VIAL
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: AP
Application Number: N022023
Product Number: 002
Approval Date: Nov 12, 2010
Applicant Holder Full Name: MERCK AND CO INC
Marketing Status:  Prescription
Patent and Exclusivity Information

EMEND (FOSAPREPITANT DIMEGLUMINE)
EQ 115MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Marketing Status: Discontinued

Active Ingredient: FOSAPREPITANT DIMEGLUMINE
Proprietary Name: EMEND
Dosage Form; Route of Administration: POWDER; INTRAVENOUS
Strength: EQ 115MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Reference Listed Drug: Yes
Reference Standard: No
TE Code: 
Application Number: N022023
Product Number: 001
Approval Date: Jan 25, 2008
Applicant Holder Full Name: MERCK AND CO INC
Marketing Status:  Discontinued
Patent and Exclusivity Information